Appointed by Governor: Laurie Kuiper; Marco T. A. Priolo; Eric J. Shope; Sanford K. Walters.
Appointed by Senate President: Delores G. Kelley; Thomas M. Middleton.
Appointed by House Speaker: Kirill Reznik; Christopher R. West.
Appointed by Senate President & House Speaker: Donna M. Carris; Vincent DeMarco, J.D.; Lori Doyle; Jamal Lee; Deborah R. Rivkin.
Representing Maryland Hospital Association: Robert O. Atlas, M.D.
Representing MedChi: Stephen J. Rockower, M.D.
Ex officio: Carolyn A. Quattrocki, designee of Attorney General; Robert R. Neall, Secretary of Health; Joseph B. Fitzpatrick, designee of Maryland Insurance Commissioner.
Staff: Laura E. Goodman (410) 767-5683; e-mail: firstname.lastname@example.org
c/o Office of Secretary, Maryland Department of Health
Herbert R. O'Conor State Office Building, 201 West Preston St., Baltimore, MD 21201 - 2399
Staff: Michael Paddy (410) 468-2408; e-mail: email@example.com
c/o Maryland Insurance Commissioner, Maryland Insurance Administration
St. Paul Plaza, Suite 2700
200 St. Paul Place, Baltimore, MD 21202 - 2272
St. Paul Plaza, 200 St. Paul Place, Baltimore, Maryland, July 2007. Photo by Diane F. Evartt.
In June 2017, the Maryland Health Insurance Coverage Protection Commission was authorized (Chapter 17, Acts of 2017).
Changes and proposed changes to the federal Patient Protection and Affordable Care Act, the Maryland Children's Health Program, Medicaid, Medicare, and the Maryland All-Payer Model will be monitored by the Commission. Their impact will be assessed by the Commission, and recommendations will be made on how to ensure that Maryland residents have access to affordable health coverage.
The Commission will assess the adverse effects on State residents, public health, and the economy resulting from the loss of health coverage through changes to the federal Patient Protection and Affordable Care Act. Moreover, it will estimate the costs of such changes to Maryland and its residents, and examine measures to prevent or mitigate their adverse effects on the Maryland Children's Health Program, Medicaid, Medicare, and the Maryland All-Payer Model.
In April 2018, the Commission further was charged with undertaking a study of options for ensuring stability in the individual and group health insurance markets. Commission findings and recommendations are to be included in its 2019 annual report (Chapters 37 & 38, Acts of 2018).
Authorization for the Commission ends June 30, 2020.
|| Search the Archives || Education & Outreach || Archives of Maryland Online ] Governor General Assembly Judiciary Maryland.Gov